| Rosemarie Florian, MD | |
|
11234 Anderson St Rm 1503, Loma Linda, CA 92350 | |
| (909) 558-7263 | |
| Not Available |
| Full Name | Rosemarie Florian |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 9 Years |
| Location | 11234 Anderson St Rm 1503, Loma Linda, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275911844 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | A148259 (California) | Secondary |
| 207R00000X | Internal Medicine | A148259 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Loma Linda University Medical Center | Loma linda, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Faculty Physicians And Surgeons Of Llusm | 1153227814 | 1053 |
News Archive
In this opinion piece in Stanford University's "Policy Review," Mark Dybul, a distinguished scholar and the inaugural global health fellow at the George W. Bush Institute; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Julio Frenk, dean of the Harvard School of Public Health, discuss the need for "a structural and philosophical shift" in the global health field, writing, "As we approach the post-[Millennium Development Goal] era, now is the time for a new framework to establish an accelerated trajectory to achieve a healthy world."
The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Osteoporosis is a serious health condition that affects over 44 million Americans. The human and economic costs for this condition may account for some $17 billion in direct expenditures in hospitals and nursing homes and that annual expense is expected to triple by 2040.
Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients with advanced pancreatic cancer. The Principal Investigator is Dr. Monica Mita of the CTRC.
With the start of summer comes the appearance of common stinging insects, such as bees, wasps, hornets and yellowjackets, and the various related health risks that range from irritating but relatively harmless stings to the threat of serious allergic reaction. The National Pest Management Association (NPMA) stresses that when it comes to stinging insects, the best way to avoid the associated health risks is to practice simple prevention and treatment tips.
› Verified 7 days ago
| Entity Name | Faculty Physicians And Surgeons Of Llusm |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205009917 PECOS PAC ID: 1153227814 Enrollment ID: O20031211000981 |
News Archive
In this opinion piece in Stanford University's "Policy Review," Mark Dybul, a distinguished scholar and the inaugural global health fellow at the George W. Bush Institute; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Julio Frenk, dean of the Harvard School of Public Health, discuss the need for "a structural and philosophical shift" in the global health field, writing, "As we approach the post-[Millennium Development Goal] era, now is the time for a new framework to establish an accelerated trajectory to achieve a healthy world."
The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Osteoporosis is a serious health condition that affects over 44 million Americans. The human and economic costs for this condition may account for some $17 billion in direct expenditures in hospitals and nursing homes and that annual expense is expected to triple by 2040.
Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients with advanced pancreatic cancer. The Principal Investigator is Dr. Monica Mita of the CTRC.
With the start of summer comes the appearance of common stinging insects, such as bees, wasps, hornets and yellowjackets, and the various related health risks that range from irritating but relatively harmless stings to the threat of serious allergic reaction. The National Pest Management Association (NPMA) stresses that when it comes to stinging insects, the best way to avoid the associated health risks is to practice simple prevention and treatment tips.
› Verified 7 days ago
| Entity Name | Faculty Physicians And Surgeons Of Llusm |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508255175 PECOS PAC ID: 1153227814 Enrollment ID: O20160216002196 |
News Archive
In this opinion piece in Stanford University's "Policy Review," Mark Dybul, a distinguished scholar and the inaugural global health fellow at the George W. Bush Institute; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Julio Frenk, dean of the Harvard School of Public Health, discuss the need for "a structural and philosophical shift" in the global health field, writing, "As we approach the post-[Millennium Development Goal] era, now is the time for a new framework to establish an accelerated trajectory to achieve a healthy world."
The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Osteoporosis is a serious health condition that affects over 44 million Americans. The human and economic costs for this condition may account for some $17 billion in direct expenditures in hospitals and nursing homes and that annual expense is expected to triple by 2040.
Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients with advanced pancreatic cancer. The Principal Investigator is Dr. Monica Mita of the CTRC.
With the start of summer comes the appearance of common stinging insects, such as bees, wasps, hornets and yellowjackets, and the various related health risks that range from irritating but relatively harmless stings to the threat of serious allergic reaction. The National Pest Management Association (NPMA) stresses that when it comes to stinging insects, the best way to avoid the associated health risks is to practice simple prevention and treatment tips.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rosemarie Florian, MD 11234 Anderson St Rm 1503, Loma Linda, CA 92350-1716 Ph: (909) 558-7263 | Rosemarie Florian, MD 11234 Anderson St Rm 1503, Loma Linda, CA 92350 Ph: (909) 558-7263 |
News Archive
In this opinion piece in Stanford University's "Policy Review," Mark Dybul, a distinguished scholar and the inaugural global health fellow at the George W. Bush Institute; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Julio Frenk, dean of the Harvard School of Public Health, discuss the need for "a structural and philosophical shift" in the global health field, writing, "As we approach the post-[Millennium Development Goal] era, now is the time for a new framework to establish an accelerated trajectory to achieve a healthy world."
The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Osteoporosis is a serious health condition that affects over 44 million Americans. The human and economic costs for this condition may account for some $17 billion in direct expenditures in hospitals and nursing homes and that annual expense is expected to triple by 2040.
Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients with advanced pancreatic cancer. The Principal Investigator is Dr. Monica Mita of the CTRC.
With the start of summer comes the appearance of common stinging insects, such as bees, wasps, hornets and yellowjackets, and the various related health risks that range from irritating but relatively harmless stings to the threat of serious allergic reaction. The National Pest Management Association (NPMA) stresses that when it comes to stinging insects, the best way to avoid the associated health risks is to practice simple prevention and treatment tips.
› Verified 7 days ago
Petru Papacostea, Internal Medicine Medicare: Medicare Enrolled Practice Location: 11201 Benton St, Loma Linda, CA 92357 Phone: 909-825-7084 | |
Dr. Moosa Azadian, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11234 Anderson St, Loma Linda, CA 92354 Phone: 909-558-4085 | |
Douglas Wang, Internal Medicine Medicare: Medicare Enrolled Practice Location: 11234 Anderson Street, Gme Office Westerly Suite C, Loma Linda, CA 92354 Phone: 909-558-4174 | |
Dr. Lynnetta E Skoretz, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11201 Benton Street, #111h, Loma Linda, CA 92357 Phone: 909-825-7084 Fax: 909-777-3280 | |
Shahab Sean Shahangian, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 11234 Anderson St, Loma Linda, CA 92354 Phone: 818-532-8211 | |
Mst Nurjahan Khatun, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 11234 Anderson St # C, Loma Linda, CA 92354 Phone: 408-355-8650 | |
Snorri Olafsson, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 11370 Anderson St, Ste 3150, Loma Linda, CA 92354 Phone: 909-558-2191 |